Letter: The risk-benefit balance of CRISPR-Cas screening systems in gene editing and targeted cancer therapy by Qiang Yi, Xinting Ouyang, Gangfeng Zhu, Jinghua Zhong

Get full text

circFOXP1: a potential diagnostic and therapeutic target in human diseases by Qiang Yi, Xinting Ouyang, Kui Zhong, Zheng Chen, Weijian Zhu, Gangfeng Zhu, Jinghua Zhong

Get full text

Development and validation of a machine learning model for predicting pulmonary metastasis in hepatocellular carcinoma patients by Gangfeng Zhu, Qiang Yi, Rui Xu, Yi Xie, Siying Chen, Yipeng Song, Yi Xiang, Xiangcai Wang, Li Huang

Get full text

Machine learning models for predicting metabolic dysfunction-associated steatotic liver disease prevalence using basic demographic and clinical characteristics by Gangfeng Zhu, Yipeng Song, Zenghong Lu, Qiang Yi, Rui Xu, Yi Xie, Shi Geng, Na Yang, Liangjian Zheng, Xiaofei Feng, Rui Zhu, Xiangcai Wang, Li Huang, Yi Xiang

Get full text